Literature DB >> 14739103

Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice.

Claudio A Redaelli1, David Semela, Francine E Carrick, Monika Ledermann, Daniel Candinas, Bernhard Sauter, Jean-François Dufour.   

Abstract

BACKGROUND/AIMS: Liver regeneration is dependent upon coordinated proliferation of hepatocytes and endothelial cells. Vascular endothelial growth factor (VEGF) promotes angiogenesis. Hepatic steatosis delays regeneration and increases liver resection morbidity. We hypothesized that VEGF overexpression stimulates hepatic regeneration.
METHODS: Recombinant adenovirus expressing human VEGF165 or adenovirus control-vector (LacZ) were administered before 2/3 hepatectomy in lean and ob/ob mice. Galactose elimination capacity, a quantitative liver function test, was repeatedly measured before and after hepatectomy. Expression of VEGF receptors (flt1, flk1), endoglin and hypoxia inducible factor-1alpha (HIF-1alpha) was assessed by quantitative RT-PCR and for endoglin also by immunohistochemistry.
RESULTS: After 2/3 hepatectomy, VEGF gene transfer increased galactose elimination capacity in lean and ob/ob mice. HIF-1alpha, endoglin and VEGF receptor mRNA increased during regeneration in lean but not in obese mice. Staining of endothelial cells by endoglin immunohistochemistry returned to baseline reactivity in lean mice by day 6 and remained decreased in ob/ob mice. VEGF treatment decreased HIF-1alpha and increased flk1 response in lean mice.
CONCLUSIONS: Hepatic resection elicits an angiogenic response in the remnant liver, which is impaired in case of steatosis. Adenovirus-mediated transfer of VEGF hastens functional hepatic recovery in lean, and more importantly also, in obese mice after partial hepatectomy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739103     DOI: 10.1016/j.jhep.2003.10.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury.

Authors:  Sei-ichiro Tsuchihashi; Bibo Ke; Fady Kaldas; Evelyn Flynn; Ronald W Busuttil; David M Briscoe; Jerzy W Kupiec-Weglinski
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Role of cytokine levels in assessment of prognosis and post-treatment outcome in hepatocellular carcinoma.

Authors:  Moana Gelu-Simeon; Didier Samuel
Journal:  Hepatol Int       Date:  2013-09-10       Impact factor: 6.047

3.  The effect of sorafenib on liver regeneration and angiogenesis after partial hepatectomy in rats.

Authors:  K Kiroplastis; I Fouzas; E Katsiki; K Patsiaoura; M Daoudaki; A Komninou; E Xolongitas; E Katsika; K Kaidoglou; V Papanikolaou
Journal:  Hippokratia       Date:  2015 Jul-Sep       Impact factor: 0.471

4.  Inhibition of VEGF- and NO-dependent angiogenesis does not impair liver regeneration.

Authors:  U Shergill; A Das; D Langer; Rs Adluri; N Maulik; V H Shah
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05       Impact factor: 3.619

Review 5.  Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.

Authors:  Bharath Nath; Gyongyi Szabo
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

6.  Effect of different liver resection methods on liver damage and regeneration factors VEGF and FGF-2 in mice.

Authors:  Roderich Bönninghoff; Kay Schwenke; Michael Keese; Richard Magdeburg; Hinrich Bitter-Suermann; Mirko Otto; Till Hasenberg; Stefan Post; Jörg Sturm
Journal:  Can J Surg       Date:  2012-12       Impact factor: 2.089

7.  Advances in therapeutics for liver metastasis from colorectal cancer.

Authors:  Akira Kobayashi; Shinichi Miyagawa
Journal:  World J Gastrointest Oncol       Date:  2010-10-15

8.  Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells.

Authors:  Kathrin Rupertus; Otto Kollmar; Claudia Scheuer; Bastian Junker; Michael D Menger; Martin K Schilling
Journal:  Clin Exp Metastasis       Date:  2007-01-27       Impact factor: 5.150

Review 9.  Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance.

Authors:  Giovanni Tarantino; Silvia Savastano; Annamaria Colao
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

10.  Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study.

Authors:  Mahfud Mahfud; Stefan Breitenstein; Ashraf Mohammad El-Badry; Milo Puhan; Andreas Rickenbacher; Panagiotis Samaras; Patrick Pessaux; Santiago Lopez-Ben; Daniel Jaeck; Joan Figueras; Pierre Alain-Clavien
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.